SmPC- Bivalirudin 250 mg Powder for Concentrate for solution for injection or infusion: Change history
View Summary of Product Characteristics (SmPC- Bivalirudin 250 mg Powder for Concentrate for solution for injection or infusion)
Last updated on this site: 09 Sep 2026
Expanded Renewal: updates to SPC sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 6.5, 6.6, 9 and 10, PIL and labelling.
MHRA approval date: 07/09/2026
View Summary of Product Characteristics (SmPC- Bivalirudin 250 mg Powder for Concentrate for solution for injection or infusion)
Last updated on this site: 09 Sep 2026
Expanded Renewal: updates to SPC sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 6.5, 6.6, 9 and 10, PIL and labelling.
MHRA approval date: 07/09/2026
-
Changes: (Updated: 09 Sep 2026)
Expanded Renewal: updates to SPC sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 6.5, 6.6, 9 and 10, PIL and labelling.
MHRA approval date: 07/09/2026
-
Changes: (Updated: 20 Sep 2022)
Initial upload